Stocks and Investing
Stocks and Investing
Mon, August 14, 2017
[ 12:00 AM ] - United States, WOPRAI
Fri, August 11, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, August 10, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Steve Beuchaw Maintained (XRAY) at Buy with Increased Target to $67 on, Aug 10th, 2017
Steve Beuchaw of Morgan Stanley, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy with Increased Target from $66 to $67 on, Aug 10th, 2017.
Steve has made no other calls on XRAY in the last 4 months.
There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 0 agree with Steve's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Steve
- Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $74 on, Tuesday, July 11th, 2017
- Robert Jones of "Goldman Sachs" Downgraded from Hold to Strong Sell on, Tuesday, May 23rd, 2017
Contributing Sources